Intermolecular

Intermolecular provides high productivity combinatorial technology products and services for a wide range of industries. The Company's HPC platform, which consists of its Tempus processing tools, unique, automated characterization methods, and its Informatics analysis software, is purpose-built for research and development using combinatorial process systems in concert with established CVD, physical vapor deposition, and atomic layer deposition methods. Combinatorial processing is a methodology for experimentation, discovery, and development that employs parallel and other high-throughput experimentation, which allows R&D experimentation to be performed at speeds up to 100 times faster than conventional R&D platforms, which are optimized for manufacturing rather than for R&D.
Company Growth (employees)
Type
Public
HQ
San Jose, US
Founded
2004
Size (employees)
145 (est)
Intermolecular was founded in 2004 and is headquartered in San Jose, US

Key People at Intermolecular

Tony Chiang, Ph.D

Tony Chiang, Ph.D

CTO

Intermolecular Office Locations

Intermolecular has an office in San Jose
San Jose, US (HQ)
3011 N 1st St

Intermolecular Data and Metrics

Intermolecular Financial Metrics

Intermolecular's revenue was reported to be $9.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

9.9 m

Gross profit (Q1, 2017)

7 m

Gross profit margin (Q1, 2017), %

70%

Net income (Q1, 2017)

(5.8 m)

EBIT (Q1, 2017)

(6 m)

Market capitalization (15-Aug-2017)

44.8 m

Cash (31-Mar-2017)

7.6 m
Intermolecular's current market capitalization is $44.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4 m47.7 m45.3 m47.3 m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5 m24.7 m19.3 m15.8 m

Gross profit

34.9 m23 m26 m31.5 m

Gross profit Margin, %

52%48%57%67%

Sales and marketing expense

7.4 m

R&D expense

28.1 m

General and administrative expense

10.7 m

Operating expense total

43 m44.1 m46.7 m47.3 m

EBIT

(8 m)(21 m)(20.7 m)(15.9 m)

EBIT margin, %

(12%)(44%)(46%)(34%)

Interest expense

830 k682 k267 k173 k

Interest income

173 k

Pre tax profit

(8.8 m)(21.8 m)(21 m)(15.4 m)

Income tax expense

17 k7 k8 k7 k

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

9.9 m10.9 m9.8 m11 m11.5 m14.5 m11.7 m10.6 m9.9 m

Cost of goods sold

5.6 m6.2 m5.5 m4.6 m5 m4.8 m4.1 m3.5 m3 m

Gross profit

4.3 m4.7 m4.4 m6.4 m6.5 m9.7 m7.6 m7.1 m7 m

Gross profit Margin, %

43%43%44%58%56%67%65%67%70%

Sales and marketing expense

1.4 m1.3 m1.3 m1.6 m1.6 m1.9 m2.1 m1.8 m1.5 m

R&D expense

6.2 m5 m6.5 m7.2 m7.4 m6.9 m6.9 m8.5 m7.1 m

General and administrative expense

3.1 m3.1 m3.4 m3.2 m3.2 m2.6 m2.7 m2.7 m3 m

Operating expense total

10.7 m9.5 m11.2 m11.9 m12.2 m11.4 m11.7 m12.9 m11.6 m

EBIT

(6.7 m)(4.8 m)(6.9 m)(5.6 m)(5.8 m)(1.7 m)(4.1 m)(6.9 m)(6 m)

EBIT margin, %

(67%)(44%)(70%)(51%)(50%)(12%)(35%)(65%)(60%)

Interest expense

(179 k)(159 k)(134 k)(121 k)(52 k)32 k40 k51 k55 k

Interest income

32 k40 k51 k55 k

Pre tax profit

(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)

Income tax expense

2 k1 k3 k2 k2 k3 k1 k3 k800

Net Income

(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

72.1 m21.8 m11.7 m5.8 m

Inventories

2.2 m1.8 m1.6 m1.4 m

Current Assets

81.4 m72.2 m43.1 m32.3 m

PP&E

28.5 m19.1 m15.7 m11 m

Total Assets

124.5 m105.4 m69.7 m53.2 m

Accounts Payable

2.2 m862 k848 k309 k

Current Liabilities

14 m10.1 m10.2 m5 m

Total Liabilities

8.2 m

Additional Paid-in Capital

194.9 m202.1 m209 m213.3 m

Retained Earnings

(110.1 m)(131.9 m)(152.9 m)(168.3 m)

Total Equity

56.1 m45 m

Financial Leverage

1.2 x1.2 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

41.8 m22.1 m25.6 m14.4 m3.3 m17.1 m16.4 m9.7 m7.6 m

Inventories

7.3 m7.4 m

Current Assets

76 m74 m68.9 m66.6 m43.5 m35.9 m37.9 m34.5 m32.6 m

PP&E

24.5 m21.7 m18 m16.5 m16.1 m15.4 m14.4 m12 m9.8 m

Total Assets

116.2 m111.4 m100.4 m96.2 m71.6 m66.6 m64 m57.1 m50 m

Accounts Payable

1.1 m221 k617 k1.1 m1.8 m224 k786 k327 k746 k

Current Liabilities

11.5 m10.4 m10.4 m10.6 m10.5 m7 m7.5 m6.5 m7 m

Additional Paid-in Capital

198.9 m200.6 m204.6 m206.4 m207.8 m210.8 m211.7 m212.6 m214 m

Retained Earnings

(120.8 m)(125.8 m)(138.9 m)(144.6 m)(150.4 m)(154.6 m)(158.6 m)(165.3 m)(174.2 m)

Total Equity

65.7 m61.8 m57.4 m56.3 m53.2 m47.3 m39.8 m

Financial Leverage

1.5 x1.6 x1.2 x1.2 x1.2 x1.2 x1.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)

Depreciation and Amortization

10.9 m

Accounts Receivable

1.7 m1.1 m

Inventories

2.2 m1.6 m1.6 m

Accounts Payable

2.2 m(635 k)848 k(493 k)

Cash From Operating Activities

(6.2 m)(1.9 m)(10.1 m)(5.4 m)

Purchases of PP&E

(2.8 m)(2.4 m)

Cash From Investing Activities

(47.7 m)(1.2 m)

Cash From Financing Activities

(810 k)701 k

Interest Paid

666 k9 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)

Depreciation and Amortization

2.5 m

Accounts Receivable

425 k

Inventories

7.3 m7.4 m445 k

Accounts Payable

1.1 m221 k(284 k)1.1 m1.8 m224 k786 k327 k746 k

Cash From Operating Activities

(1.8 m)

Purchases of PP&E

(927 k)

Cash From Investing Activities

5.7 m

Cash From Financing Activities

37 k

Interest Paid

191 k
USDY, 2017

Revenue/Employee

68.6 k

Financial Leverage

1.3 x

Intermolecular Market Value History

Intermolecular Median Salaries

Source: 17 public H-1B filings from Intermolecular

Traffic Overview of Intermolecular

Intermolecular Online and Social Media Presence

Intermolecular Company Life and Culture

You may also be interested in